首页>
外国专利>
Combined Inhibition Of The Vitamin D Receptor And Poly(ADP) Ribose Polymerase (PARP) In The Treatment Of Cancer
Combined Inhibition Of The Vitamin D Receptor And Poly(ADP) Ribose Polymerase (PARP) In The Treatment Of Cancer
展开▼
机译:维生素D受体和聚(ADP)核糖聚合酶(PARP)联合抑制治疗癌症
展开▼
页面导航
摘要
著录项
相似文献
摘要
Methods for treating tumors comprise contacting tumor cells expressing the vitamin D receptor with a vitamin D receptor ligand that inhibits homologous recombination in the tumor cells, and contacting the tumor cells with an amount of a Poly(ADP) Ribose Polymerase 1 (PARP-1) inhibitor. Inhibiting homologous recombination produces a synergistic therapeutic effect between the vitamin D receptor ligand and PARP-1 inhibitor, and may overcome PARP-1 resistance in killing tumor cells.
展开▼